Difference between revisions of "IVAX Corporation"

From Powerbase
Jump to: navigation, search
(→‎Brands, Divisions and Affiliates)
 
(9 intermediate revisions by 2 users not shown)
Line 1: Line 1:
−
The Ivax Corporation is a huge Florida-based health company. [[Norton Healthcare]], the largest generic drugs company in Britain, is a subsidiary of IVAX. [[Isaac Kaye]] earned $550,301 at IVAX in 1998 (plus share options worth up to $1.5 million) and $521,520 in 1997.<ref>Ref needed</ref>. In 2006 IVAX was aquired by [[Teva]] which is described as 'Israel's largest company'.<ref>Teva, [http://www.tevapharm.com/financial/teva-ivax.asp IVAX Acquisition], accessed 23 May 2008</ref> The aquisition is reported to have created 'the world's largest generics company'.<ref>Maguire K (2002) [http://www.guardian.co.uk/uk/2002/apr/13/politics.partyfunding Profile:Isaac Kaye] <i>The Guardian</i> 13th April 2002. Accessed 4th April 2008</ref>.
+
The Ivax Corporation is a huge Florida-based health company. [[Norton Healthcare]], the largest generic drugs company in Britain, is a subsidiary of IVAX. Norton's Head Office is located London's Docklands and, according to Chairman and CEO [[Isaac Kaye]], it was positioned there 'owing to the area's proximity to the City of London and to the [[European Medicines Evaluation Agency]]'<ref>Hermes Database '300% Increase In New Jobs Created By US Investment' 16th June 1999</ref>
 +
 
 +
[[Isaac Kaye]] earned $550,301 at IVAX in 1998 (plus share options worth up to $1.5 million) and $521,520 in 1997.<ref>Ref needed</ref>. In 2006 IVAX was aquired by [[Teva]] which is described as 'Israel's largest company'.<ref>Teva, [http://www.tevapharm.com/financial/teva-ivax.asp IVAX Acquisition], accessed 23 May 2008</ref> The aquisition is reported to have created 'the world's largest generics company'.<ref>Maguire K (2002) [http://www.guardian.co.uk/uk/2002/apr/13/politics.partyfunding Profile:Isaac Kaye] <i>The Guardian</i> 13th April 2002. Accessed 4th April 2008</ref>.
  
 
Kaye is reported to have stepped down as chairman of Norton Healthcare in 2003<ref>Brogan, B. & Gysin, C. (2008) Hain faces sack in sleaze inquiry; He could be barred - but Brown might fire him first. <i>The Daily Mail</i> (London). 12th January 2008</ref>. <i>Plunkett's Health Care Industry Almanac</i> reports IVAX profits totalling $243,200,000 for 2001, $131,000,000 for 2000 and $70,700,000 for 1999. Their sales totals were $1,215,400,000, $793,400,000, and $656,500,000 respectively.
 
Kaye is reported to have stepped down as chairman of Norton Healthcare in 2003<ref>Brogan, B. & Gysin, C. (2008) Hain faces sack in sleaze inquiry; He could be barred - but Brown might fire him first. <i>The Daily Mail</i> (London). 12th January 2008</ref>. <i>Plunkett's Health Care Industry Almanac</i> reports IVAX profits totalling $243,200,000 for 2001, $131,000,000 for 2000 and $70,700,000 for 1999. Their sales totals were $1,215,400,000, $793,400,000, and $656,500,000 respectively.
 +
 +
In 2001, IVAX is reported to have 'achieved record earnings of $1.2bn'<ref>McGee, H. (2002) 'Alleged fraud firm linked to millionaire with Irish passport'. <i>Sunday Tribune</i> (Ireland). 14th April 2002</ref>
  
 
==People==
 
==People==
 
*[[Isaac Kaye]]
 
*[[Isaac Kaye]]
  
−
In 2003, the following people are reported as serving IVAX<ref><i>FD (Fair Disclosure) Wire</i> 'Q1 2003 Ivax Earnings Conference Call - Final'. 24th April 2003</ref>...
+
In 2003, the following people are reported as serving IVAX...
−
* [[Dan Weiner]] - Senior Vice President for Global Clinical Development
+
* [[Frank Condella]] - Managing Director in the UK <ref><i>Company News</i> 'IVAX Corporation - Directorate Change'. 22nd April 2003</ref>
−
* [[Steve Marcus]] - Senior Vice President for Proprietary Pharmaceutical Business Development.
+
* [[Dan Weiner]] - Senior Vice President for Global Clinical Development<ref><i>FD (Fair Disclosure) Wire</i> 'Q1 2003 Ivax Earnings Conference Call - Final'. 24th April 2003</ref>
−
* [[Nick Vodar]] - Director of Drug Discovery and the Director of IVAx's Institute for Drug Research in Budapest, Hungary.
+
* [[Steve Marcus]] - Senior Vice President for Proprietary Pharmaceutical Business Development<ref><i>FD (Fair Disclosure) Wire</i> 'Q1 2003 Ivax Earnings Conference Call - Final'. 24th April 2003</ref>.
−
* [[Betty Amos]] - Board member
+
* [[Nick Vodar]] - Director of Drug Discovery and the Director of IVAx's Institute for Drug Research in Budapest, Hungary<ref><i>FD (Fair Disclosure) Wire</i> 'Q1 2003 Ivax Earnings Conference Call - Final'. 24th April 2003</ref>.
−
* [[Mitch Medique]] - Board member. Medique also serves on the board of several public companies (including [[National Semiconductor]] and [[Carnival Corporations]]).
+
* [[Betty Amos]] - Board member. Amos is the owner and president of The [[Abkey Companies]] and a franchisee of [[Fuddruckers]] restaurants<ref><i>Company News</i> 'IVAX Corporation - Directorate Change'. 22nd April 2003</ref>.
−
* [[Burt Pitt]]. Pitt is also a professor of cardiology at the University of Michigan School of Medicine.
+
* [[Mitch Medique]] - Board member. Medique also serves on the board of several public companies (including [[National Semiconductor]] and [[Carnival Corporations]])<ref><i>FD (Fair Disclosure) Wire</i> 'Q1 2003 Ivax Earnings Conference Call - Final'. 24th April 2003</ref>. He is also a past chairman of The [[Beacon Council]] (Miami's economic development authority)<ref><i>Company News</i> 'IVAX Corporation - Directorate Change'. 22nd April 2003</ref>
 +
* [[Burt Pitt]]. Pitt is also a professor of cardiology at the University of Michigan School of Medicine<ref><i>FD (Fair Disclosure) Wire</i> 'Q1 2003 Ivax Earnings Conference Call - Final'. 24th April 2003</ref>.
 +
* [[Philip Frost]] - Board member<ref><i>Company News</i> 'IVAX Corporation - Directorate Change'. 22nd April 2003</ref>
 +
* [[Neil Flanzraich]] - Board member<ref><i>Company News</i> 'IVAX Corporation - Directorate Change'. 22nd April 2003</ref>
 +
* [[Jane Hsiao]] - Board member<ref><i>Company News</i> 'IVAX Corporation - Directorate Change'. 22nd April 2003</ref>
 +
* [[Mark Andrews]] - Board member<ref><i>Company News</i> 'IVAX Corporation - Directorate Change'. 22nd April 2003</ref>
 +
* [[Ernst Biekert]]- Board member<ref><i>Company News</i> 'IVAX Corporation - Directorate Change'. 22nd April 2003</ref>
 +
* [[Jack Fishman]]- Board member<ref><i>Company News</i> 'IVAX Corporation - Directorate Change'. 22nd April 2003</ref>
 +
* [[Richard Pfenniger]] Jr. - Board member <ref><i>Company News</i> 'IVAX Corporation - Directorate Change'. 22nd April 2003</ref>
 +
* [[David Lieberman]] - Board member<ref><i>Company News</i> 'IVAX Corporation - Directorate Change'. 22nd April 2003</ref>
 +
 
 +
IVAX's Board of Directors in 2002 are reported as including<ref><i>Business Wire</i> 'IVAX Announces Results of 2002 Annual Shareholders' Meeting'. 27th June 2002</ref>...
 +
* [[Neil Flanzraich]] - Vice Chairman and President of IVAX Corporation
 +
* [[Jane Hsiao]] - Vice Chairman of Technical Affairs and Chief Technical Officer of IVAX Corporation.
 +
* [[Mark Andrews]] - President of [[Great Spirits Company]].
 +
* [[Ernst Biekert]] - Professor of Chemistry at the University of Heidelberg.
 +
* [[Charles M Fernandez]] - President and Chief Executive Officer of [[Big City Radio]].
 +
* [[Jack Fishman]] - Director of Research at [[Strang Cancer Research Laboratory]]
 +
* [[Richard C Pfenniger]] Jr. - Chief Executive Officer and Director of [[Whitman Education Group]], Inc.
  
 
==Aquisitions and Partnerships==
 
==Aquisitions and Partnerships==
Line 26: Line 48:
 
In 2003, [[Thomas Beier]], Senior Vice President and Chief Financial Officer for IVAX reported 'Operating expenses' which included a $6.6 million legal settlement<ref><i>FD (Fair Disclosure) Wire</i> 'Q1 2003 Ivax Earnings Conference Call - Final'. 24th April 2003</ref>. No further details were disclosed.
 
In 2003, [[Thomas Beier]], Senior Vice President and Chief Financial Officer for IVAX reported 'Operating expenses' which included a $6.6 million legal settlement<ref><i>FD (Fair Disclosure) Wire</i> 'Q1 2003 Ivax Earnings Conference Call - Final'. 24th April 2003</ref>. No further details were disclosed.
  
−
==Brands, Divisions and Affiliates==
+
==Subsidiaries and Brands==
 +
The IVAX Corporation's other subsidiaries include [[Zenith Goldline Pharmaceuticals]], [[Goldcaps Inc.]], [[Diamedix Corporation]], [[Baker Norton Pharmaceuticals]], [[Immunovision]] and [[DVM Pharmaceuticals]] (all based in Florida), [[Gelkaps GmbH]] (Germany), [[Elvetium S.A.]] (Argentina), [[Baker Norton Asia]] (Hong Kong), [[Delta Biologicals]] (Italy) and [[Galena a.s. Opava]] (Czech Republic).
 +
 
 +
In 2002, IVAX is reported to have 'recently' aquired Puerto Rican based company [[ChemSource]] (Which develops, manufactures and sells active pharmaceutical ingredients for a variety of pharmaceuticals products)<ref><i>Plunkett's Health Care Industry Almanac</i> (2002) 'Individual Data Profiles On Each Of THE HEALTH CARE 500'. January 2004</ref>
 +
 
 +
In 2002, it is also reported that IVAX 'established a company in France by acquiring [[Merck]] Sharp & Dohme's portfolio of generic products there<ref><i>FD (Fair Disclosure) Wire</i> 'Q1 2003 Ivax Earnings Conference Call - Final'. 24th April 2003</ref>. IVAX also 'entered into a collaboration with [[Novartis]]' in order to market IVAX's Airmax multidose dry powder inhaler<ref><i>FD (Fair Disclosure) Wire</i> 'Q1 2003 Ivax Earnings Conference Call - Final'. 24th April 2003</ref>.
 +
 
 +
In 2002, <i>Plunkett's Health Care Industry Almanac</i> describes IVAX's 'Brands/Divisions/Affiliates' as<ref><i>Plunkett's Health Care Industry Almanac</i> (2002) 'Individual Data Profiles On Each Of THE HEALTH CARE 500'. January 2004</ref>...
 +
* [[Airmax]]
 +
* [[Easi-Breathe]]
 +
* [[Paxene]]
 +
* [[Paxoral]]
 +
* [[TP-38]]
 +
* [[ChemSource Corporation]].
 +
* [[IVAX Pharmaceuticals Inc.]]
 +
===Brands, Divisions and Affiliates===
 
*[[Norton Healthcare]]
 
*[[Norton Healthcare]]
 
In 2004, <i>Plunkett's Health Care Industry Almanac</i> reports the following 'Brands/Divisions/Affiliates' of IVAX<ref> <i>Plunkett's Health Care Industry Almanac</i>. 'IVAX Corporation.' January 2004</ref>...  
 
In 2004, <i>Plunkett's Health Care Industry Almanac</i> reports the following 'Brands/Divisions/Affiliates' of IVAX<ref> <i>Plunkett's Health Care Industry Almanac</i>. 'IVAX Corporation.' January 2004</ref>...  
Line 37: Line 74:
 
* [[IVAX Pharmaceuticals Inc.]]
 
* [[IVAX Pharmaceuticals Inc.]]
 
* [[Novartis]] Pharma AG
 
* [[Novartis]] Pharma AG
 +
 +
In 2001, IVAX announced that it had acquired 99.9% of the shares of [[Laboratorio Chile]] S.A<ref>The Regulatory News Service 'IVAX Corporation - Letter to shareholders'. 20th September 2001</ref>
 +
 +
IVAX acquired [[Laboratorios Elmor]] S.A. in 2000 (located in Caracas, Venezuela)<ref>The Regulatory News Service 'IVAX Corporation - Letter to shareholders'. 20th September 2001</ref>
 +
 +
In 1996, IVAX merged with the [[Bergen Brunswig Corporation]](which provided American wide distribution of pharmaceuticals and medical-surgical supplies to
 +
chain and independent pharmacies, hospitals, HMOs, nursing homes, clinics and physician groups) to create [[BBI Healthcare]]. <ref><i>Business Wire</i>. 'BERGEN BRUNSWIG AND IVAX SIGN $ 3.2 BILLION DEFINITIVE MERGER AGREEMENT'. 11th November 1996</ref>
 +
 +
In 1991, [[Baker Cummins Pharmaceuticals]] is reported to be one of IVAX's 'principal' subsidiaries. It is 50% owned by [[Union Carbine]]<ref><i>PR Newswire</i> 'IVAX HOLDS ANNUAL MEETING OF STOCKHOLDERS'. 28th October 1991</ref>
  
 
==References==
 
==References==

Latest revision as of 14:31, 18 June 2008

The Ivax Corporation is a huge Florida-based health company. Norton Healthcare, the largest generic drugs company in Britain, is a subsidiary of IVAX. Norton's Head Office is located London's Docklands and, according to Chairman and CEO Isaac Kaye, it was positioned there 'owing to the area's proximity to the City of London and to the European Medicines Evaluation Agency'[1]

Isaac Kaye earned $550,301 at IVAX in 1998 (plus share options worth up to $1.5 million) and $521,520 in 1997.[2]. In 2006 IVAX was aquired by Teva which is described as 'Israel's largest company'.[3] The aquisition is reported to have created 'the world's largest generics company'.[4].

Kaye is reported to have stepped down as chairman of Norton Healthcare in 2003[5]. Plunkett's Health Care Industry Almanac reports IVAX profits totalling $243,200,000 for 2001, $131,000,000 for 2000 and $70,700,000 for 1999. Their sales totals were $1,215,400,000, $793,400,000, and $656,500,000 respectively.

In 2001, IVAX is reported to have 'achieved record earnings of $1.2bn'[6]

People

In 2003, the following people are reported as serving IVAX...

IVAX's Board of Directors in 2002 are reported as including[23]...

Aquisitions and Partnerships

In 2004, IVAX is reported to have aquired ChemSource Corporation (which is based in Puerto Rico)[24] .

ChemSource is reported to have 'recently entered into a license agreement with Novartis Pharma AG to utilize the patented multi-dose dry powder inhaler, Airmax, for Novartis's trademarked medicines Foradil and Miflonide in the European Union and certain other countries'[25].

In 2002, it is reported that IVAX 'established a company in France by acquiring Merck Sharp & Dohme's portfolio of generic products there[26].

Litigation

In July 2003, Business Wire reports that IVAX 'received the first of a series of payments from B Braun Melsungen AG, under a number of agreements, for certain patent and product rights and for settlement of litigation'[27]. No further details were disclosed.

In 2003, Thomas Beier, Senior Vice President and Chief Financial Officer for IVAX reported 'Operating expenses' which included a $6.6 million legal settlement[28]. No further details were disclosed.

Subsidiaries and Brands

The IVAX Corporation's other subsidiaries include Zenith Goldline Pharmaceuticals, Goldcaps Inc., Diamedix Corporation, Baker Norton Pharmaceuticals, Immunovision and DVM Pharmaceuticals (all based in Florida), Gelkaps GmbH (Germany), Elvetium S.A. (Argentina), Baker Norton Asia (Hong Kong), Delta Biologicals (Italy) and Galena a.s. Opava (Czech Republic).

In 2002, IVAX is reported to have 'recently' aquired Puerto Rican based company ChemSource (Which develops, manufactures and sells active pharmaceutical ingredients for a variety of pharmaceuticals products)[29]

In 2002, it is also reported that IVAX 'established a company in France by acquiring Merck Sharp & Dohme's portfolio of generic products there[30]. IVAX also 'entered into a collaboration with Novartis' in order to market IVAX's Airmax multidose dry powder inhaler[31].

In 2002, Plunkett's Health Care Industry Almanac describes IVAX's 'Brands/Divisions/Affiliates' as[32]...

Brands, Divisions and Affiliates

In 2004, Plunkett's Health Care Industry Almanac reports the following 'Brands/Divisions/Affiliates' of IVAX[33]...

In 2001, IVAX announced that it had acquired 99.9% of the shares of Laboratorio Chile S.A[34]

IVAX acquired Laboratorios Elmor S.A. in 2000 (located in Caracas, Venezuela)[35]

In 1996, IVAX merged with the Bergen Brunswig Corporation(which provided American wide distribution of pharmaceuticals and medical-surgical supplies to chain and independent pharmacies, hospitals, HMOs, nursing homes, clinics and physician groups) to create BBI Healthcare. [36]

In 1991, Baker Cummins Pharmaceuticals is reported to be one of IVAX's 'principal' subsidiaries. It is 50% owned by Union Carbine[37]

References

  1. ↑ Hermes Database '300% Increase In New Jobs Created By US Investment' 16th June 1999
  2. ↑ Ref needed
  3. ↑ Teva, IVAX Acquisition, accessed 23 May 2008
  4. ↑ Maguire K (2002) Profile:Isaac Kaye The Guardian 13th April 2002. Accessed 4th April 2008
  5. ↑ Brogan, B. & Gysin, C. (2008) Hain faces sack in sleaze inquiry; He could be barred - but Brown might fire him first. The Daily Mail (London). 12th January 2008
  6. ↑ McGee, H. (2002) 'Alleged fraud firm linked to millionaire with Irish passport'. Sunday Tribune (Ireland). 14th April 2002
  7. ↑ Company News 'IVAX Corporation - Directorate Change'. 22nd April 2003
  8. ↑ FD (Fair Disclosure) Wire 'Q1 2003 Ivax Earnings Conference Call - Final'. 24th April 2003
  9. ↑ FD (Fair Disclosure) Wire 'Q1 2003 Ivax Earnings Conference Call - Final'. 24th April 2003
  10. ↑ FD (Fair Disclosure) Wire 'Q1 2003 Ivax Earnings Conference Call - Final'. 24th April 2003
  11. ↑ Company News 'IVAX Corporation - Directorate Change'. 22nd April 2003
  12. ↑ FD (Fair Disclosure) Wire 'Q1 2003 Ivax Earnings Conference Call - Final'. 24th April 2003
  13. ↑ Company News 'IVAX Corporation - Directorate Change'. 22nd April 2003
  14. ↑ FD (Fair Disclosure) Wire 'Q1 2003 Ivax Earnings Conference Call - Final'. 24th April 2003
  15. ↑ Company News 'IVAX Corporation - Directorate Change'. 22nd April 2003
  16. ↑ Company News 'IVAX Corporation - Directorate Change'. 22nd April 2003
  17. ↑ Company News 'IVAX Corporation - Directorate Change'. 22nd April 2003
  18. ↑ Company News 'IVAX Corporation - Directorate Change'. 22nd April 2003
  19. ↑ Company News 'IVAX Corporation - Directorate Change'. 22nd April 2003
  20. ↑ Company News 'IVAX Corporation - Directorate Change'. 22nd April 2003
  21. ↑ Company News 'IVAX Corporation - Directorate Change'. 22nd April 2003
  22. ↑ Company News 'IVAX Corporation - Directorate Change'. 22nd April 2003
  23. ↑ Business Wire 'IVAX Announces Results of 2002 Annual Shareholders' Meeting'. 27th June 2002
  24. ↑ Plunkett's Health Care Industry Almanac. 'IVAX Corporation.' January 2004
  25. ↑ Plunkett's Health Care Industry Almanac. 'IVAX Corporation.' January 2004
  26. ↑ FD (Fair Disclosure) Wire 'Q1 2003 Ivax Earnings Conference Call - Final'. 24th April 2003
  27. ↑ Business Wire 'IVAX Reports Increased Revenues and Net Income for 2nd Quarter of 2003; 2Q2003 Net Revenues Up 22% to $343 Million, Net Income Up 30% to $41.3 Million' 30th July 2003. Miami
  28. ↑ FD (Fair Disclosure) Wire 'Q1 2003 Ivax Earnings Conference Call - Final'. 24th April 2003
  29. ↑ Plunkett's Health Care Industry Almanac (2002) 'Individual Data Profiles On Each Of THE HEALTH CARE 500'. January 2004
  30. ↑ FD (Fair Disclosure) Wire 'Q1 2003 Ivax Earnings Conference Call - Final'. 24th April 2003
  31. ↑ FD (Fair Disclosure) Wire 'Q1 2003 Ivax Earnings Conference Call - Final'. 24th April 2003
  32. ↑ Plunkett's Health Care Industry Almanac (2002) 'Individual Data Profiles On Each Of THE HEALTH CARE 500'. January 2004
  33. ↑ Plunkett's Health Care Industry Almanac. 'IVAX Corporation.' January 2004
  34. ↑ The Regulatory News Service 'IVAX Corporation - Letter to shareholders'. 20th September 2001
  35. ↑ The Regulatory News Service 'IVAX Corporation - Letter to shareholders'. 20th September 2001
  36. ↑ Business Wire. 'BERGEN BRUNSWIG AND IVAX SIGN $ 3.2 BILLION DEFINITIVE MERGER AGREEMENT'. 11th November 1996
  37. ↑ PR Newswire 'IVAX HOLDS ANNUAL MEETING OF STOCKHOLDERS'. 28th October 1991
Retrieved from "https://powerbase.info/index.php?title=IVAX_Corporation&oldid=61693"